| Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors M Berk, F Kapczinski, AC Andreazza, OM Dean, F Giorlando, M Maes, ... Neuroscience & biobehavioral reviews 35 (3), 804-817, 2011 | 1325 | 2011 |
| Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis BS Fernandes, CS Gama, KM Cereser, LN Yatham, GR Fries, G Colpo, ... Journal of psychiatric research 45 (8), 995-1004, 2011 | 453 | 2011 |
| Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia M Kunz, CS Gama, AC Andreazza, M Salvador, KM Ceresér, FA Gomes, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 (7), 1677-1681, 2008 | 306 | 2008 |
| Peripheral biomarkers and illness activity in bipolar disorder F Kapczinski, F Dal-Pizzol, AL Teixeira, PVS Magalhaes, ... Journal of psychiatric research 45 (2), 156-161, 2011 | 300 | 2011 |
| Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro-and anti-inflammatory balance M Kunz, KM Ceresér, PD Goi, GR Fries, AL Teixeira, BS Fernandes, ... Brazilian Journal of Psychiatry 33, 268-274, 2011 | 264 | 2011 |
| Staging systems in bipolar disorder: an I nternational S ociety for B ipolar D isorders T ask F orce R eport F Kapczinski, PVS Magalhães, V Balanzá‐Martinez, VV Dias, S Frangou, ... Acta psychiatrica scandinavica 130 (5), 354-363, 2014 | 242 | 2014 |
| The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial M Berk, O Dean, SM Cotton, CS Gama, F Kapczinski, BS Fernandes, ... Journal of affective disorders 135 (1-3), 389-394, 2011 | 224 | 2011 |
| Increased serum S100B protein in schizophrenia: a study in medication-free patients DR Lara, CS Gama, P Belmonte-de-Abreu, LVC Portela, CA Goncalves, ... Journal of psychiatric research 35 (1), 11-14, 2001 | 218 | 2001 |
| Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder CS Gama, AC Andreazza, M Kunz, M Berk, PS Belmonte-de-Abreu, ... Neuroscience letters 420 (1), 45-48, 2007 | 200 | 2007 |
| Clinical staging in bipolar disorder: focus on cognition and functioning AR Rosa, PVS Magalhães, L Czepielewski, MV Sulzbach, PD Goi, E Vieta, ... The Journal of clinical psychiatry 75 (5), 2951, 2014 | 184 | 2014 |
| Serum brain-derived neurotrophic factor in bipolar and unipolar depression: a potential adjunctive tool for differential diagnosis BS Fernandes, CS Gama, M Kauer-Sant’Anna, MI Lobato, ... Journal of psychiatric research 43 (15), 1200-1204, 2009 | 162 | 2009 |
| Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to … D de Lucena, BS Fernandes, M Berk, S Dodd, DW Medeiros, M Pedrini, ... The Journal of clinical psychiatry 70 (10), 8775, 2009 | 157 | 2009 |
| Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity M Pedrini, R Massuda, GR Fries, MA de Bittencourt Pasquali, CE Schnorr, ... Journal of psychiatric research 46 (6), 819-824, 2012 | 155 | 2012 |
| A systemic toxicity index developed to assess peripheral changes in mood episodes F Kapczinski, F Dal-Pizzol, AL Teixeira, PVS Magalhaes, ... Molecular psychiatry 15 (8), 784-786, 2010 | 155 | 2010 |
| Staging and neuroprogression in bipolar disorder: a systematic review of the literature CS Gama, M Kunz, PVS Magalhães, F Kapczinski Brazilian Journal of Psychiatry 35, 70-74, 2013 | 144 | 2013 |
| Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine CS Gama, M Salvador, AC Andreazza, F Kapczinski, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 30 (3), 512-515, 2006 | 138 | 2006 |
| Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects C Gubert, L Stertz, B Pfaffenseller, BS Panizzutti, GT Rezin, R Massuda, ... Journal of psychiatric research 47 (10), 1396-1402, 2013 | 128 | 2013 |
| Evidences for a progressive microglial activation and increase in iNOS expression in rats submitted to a neurodevelopmental model of schizophrenia: reversal by clozapine BMM Ribeiro, MRS do Carmo, RS Freire, NFM Rocha, VCM Borella, ... Schizophrenia research 151 (1-3), 12-19, 2013 | 127 | 2013 |
| Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial M Berk, OM Dean, SM Cotton, CS Gama, F Kapczinski, B Fernandes, ... BMC medicine 10, 1-11, 2012 | 119 | 2012 |
| The association of child abuse and neglect with adult disability in schizophrenia and the prominent role of physical neglect A Gil, CS Gama, DR de Jesus, MI Lobato, M Zimmer, ... Child abuse & neglect 33 (9), 618-624, 2009 | 118 | 2009 |
Paulo Belmonte-de-AbreuFull Professor Psychiatry Faculdade de Medicina da Universidade Federal do Rio Grande do Sul, BrasilVerified email at ufrgs.br
